OPEN END TURBO PUT WARRANT - PFIZER INC | Market Closed - Boerse Frankfurt Warrants 01:33:39 2024-07-11 pm EDT | ||
| 2.81 EUR | -1.40% |
|
| Current month | -3.44% | ||
| 1 month | -3.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 2.81 | -1.40% |
| 24-07-10 | 2.85 | -2.40% |
| 24-07-09 | 2.92 | +1.04% |
| 24-07-08 | 2.89 | +0.35% |
| 24-07-05 | 2.88 | -0.35% |
Real-time Boerse Frankfurt Warrants
Last update July 11, 2024 at 01:33 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | UBS |
| WKN | UH42JU |
| ISIN | DE000UH42JU9 |
| Date issued | 2021-12-03 |
| Strike | 59 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.98 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.22 € |
|---|---|
| Lowest since issue | 0.37 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.66
USD
Average target price
32.01
USD
Spread / Average Target
+11.68%
- Stock Market
- Certificates
- Certificat
